Biden Administration Unveils Multi-Faceted Strategy to Enhance COVID-19 Vaccine Production, Distribution
The Biden administration has announced several initiatives to accelerate mass inoculations against the coronavirus, expand production of rapid coronavirus tests, and increase domestic manufacturing of surgical gloves and other essential equipment. Defense Secretary Lloyd Austin has approved the deployment of over 1,000 troops to support vaccination sites, with the first contingent of active-duty military personnel arriving in California within the next 10 days to begin operations around February 15. The administration aims to surpass the target of administering 100 million shots in the first 100 days, with a rate that modeling suggests will be insufficient to stay ahead of new variants of the virus.
Key Takeaways:
- The Biden administration is deploying over 1,000 troops to support vaccination sites, with the first contingent arriving in California within the next 10 days.
- The administration is using the Defense Production Act to prioritize the production of vaccines, expanding the priority ratings to include more equipment such as lipids, filling pumps, and filtration units.
- Pfizer has indicated it can deliver 200 million doses of its vaccine to the United States by May, two months earlier than its initial target of July.
- The administration is investing in domestic production of at-home coronavirus tests, aiming to have 61 million available by the summer.
- The country will be able to produce more than a billion surgical gloves a month by year's end, enough to satisfy about half of all American healthcare demands.
- The administration is exploring ways to expand production of N95 masks, which have been in short supply during some phases of the pandemic.
Statistics:
- 400 million vaccine doses have been contracted for in the first half of the year, enough for 200 million people under the two-dose protocols.
- The administration is seeking an additional 100 million doses from Pfizer and Moderna, with the aim of securing the doses through the summer.
- 200 million doses of Pfizer's vaccine could be delivered to the United States by May, two months earlier than its initial target of July.
- The country is currently almost entirely dependent on overseas suppliers for surgical gloves, with the goal of producing more than a billion a month by year's end.
- Overseas plants are running low on the raw material for dipping gloves, with Chaun Powell estimating the cost of gloves at 2.5 to 3.5 cents apiece.
Sources:
- The Washington Post, "Biden administration announces new steps to boost COVID-19 vaccine production, distribution"
- White House Press Briefing, February 2021
- Defense Production Act, 1950
- Department of Defense, Federal Emergency Management Agency
- The White House's coronavirus response team
- Pfizer's quarterly earnings call, 2021
- Ellume's press release, 2021
- Premier Inc., "Supplier Engagement"